Abstract
The Death Anxiety Inventory-Revised (DAI-R) is a relatively new instrument to quantify anxiety about death in different contexts. However, the dimensionality in the elderly population is unknown. The study aimed to corroborate the dimensionality of the DAI-R among Colombian-aged adults. A psychometric study was conducted with the participation of 100 aged adults (M=68.82, SD=4.82; 52% were male gender). This scale has 17 items, grouped into four dimensions or factors, and a dichotomous answer pattern. Dimensionality was tested using confirmatory factor analysis (CFA), and goodness-of-fit indicators were computed. The CFA showed unacceptable goodness-of-fit indicators, and the four-dimensional structure of the DAI-R was rejected. In conclusion, the DAI-R has an unsatisfactory four-dimensional structure among Colombian-aged adults. Further research should corroborate this finding with a large sample size.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Universidad del Magdalena, Magdalena, Santa Marta, Colombia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Board of the Universidad del Magdalena, Colombia, revised and approved the project (Act 013 of the ordinary meeting of December 2nd, 2021. The participants signed informed consent following Colombian and international standards for human participation in research, and free-use instruments without registered copyright were used.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(acampoa{at}unimagdalena.edu.co).
(mreyesr{at}unimagdalena.edu.co).
(guillermoceballos{at}gmail.com).
Declarations
Funding: Universidad del Magdalena, Magdalena, Santa Marta, Colombia.
Conflict of interest: The authors declare no interest in the research.
Ethics approval: The Research Ethics Board of the Universidad del Magdalena, Colombia, revised and approved the project (Act 013 of the ordinary meeting of December 2nd, 2021).
Consent to participate: The participants signed an informed consent.
Data availability statement: The data supporting this study’s findings are available from the corresponding author upon reasonable request.
Data Availability
The data supporting this study's findings are available from the corresponding author upon reasonable request.
